All Stories

  1. Nighttime sleep duration trajectories were associated with body mass index trajectories in early childhood
  2. Feasibility and validity of using death surveillance data and SmartVA for fact and cause of death in clinical trials in rural China: a substudy of the China salt substitute and stroke study (SSaSS)
  3. Correction to: Contribution of major food companies and their products to household dietary sodium purchases in Australia
  4. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study
  5. Lack of Strategic Funding and Long-Term Job Security Threaten to Have Profound Effects on Cardiovascular Researcher Retention in Australia
  6. Seventeen-Year Associations between Diet Quality Defined by the Health Star Rating and Mortality in Australians: The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)
  7. Prognostic Value of Secreted Frizzled-Related Protein 5 in Heart Failure Patients With and Without Type 2 Diabetes Mellitus
  8. Presence of trans fatty acids containing ingredients in pre‐packaged foods in Australia in 2018
  9. Sodium concentration of pre-packaged foods sold in Hong Kong
  10. Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double‐blinded, randomized‐controlled trial
  11. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis
  12. A comprehensive overview and qualitative analysis of government-led nutrition policies in Australian institutions
  13. Contribution of major food companies and their products to household dietary sodium purchases in Australia
  14. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies
  15. The Effects of a Supermarket-Based Intervention on the Nutritional Quality of Private-Label Foods: A Prospective Study
  16. Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study
  17. Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS)
  18. Prospective associations between depressive symptoms and cognitive functions in middle-aged and elderly Chinese adults
  19. A Systematic Review of the Sources of Dietary Salt Around the World
  20. Serial Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway and Total Mortality, Cause‐Specific Mortality, and Cardiovascular Diseases in the Cardiovascular Health Study
  21. Fish consumption for cardiovascular health: benefits from long-chain omega-3 fatty acids versus potential harms due to mercury
  22. The frequency and magnitude of price‐promoted beverages available for sale in Australian supermarkets
  23. Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality
  24. Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes
  25. Variations in Sugar Content of Flavored Milks and Yogurts: A Cross-Sectional Study across 3 Countries
  26. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  27. Nutrient profiling and food prices: what is the cost of choosing healthier products?
  28. Associations of circulating very-long-chain saturated fatty acids and incident type 2 diabetes: a pooled analysis of prospective cohort studies
  29. Association between Higher Blood Pressure and Risk of Diabetes Mellitus in Middle-Aged and Elderly Chinese Adults
  30. Barriers to implementation of a healthy canteen policy: A survey using the theoretical domains framework
  31. Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies
  32. Removal of sugary drinks from vending machines: an Australian university case study
  33. Sugar-sweetened beverages: still cause for concern in New Zealand and Australia
  34. Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes – A systematic review
  35. Measuring the Healthiness of the Packaged Food Supply in Australia
  36. Genome-wide association meta-analysis of circulating odd-numbered chain saturated fatty acids: Results from the CHARGE Consortium
  37. The nutritional content of supermarket beverages: a cross-sectional analysis of New Zealand, Australia, Canada and the UK – CORRIGENDUM
  38. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
  39. The global nutrition transition: trends, disease burdens and policy interventions
  40. Serum n–6 polyunsaturated fatty acids and risk of death: the Kuopio Ischaemic Heart Disease Risk Factor Study
  41. Healthiness of Food and Beverages for Sale at Two Public Hospitals in New South Wales, Australia
  42. The nutritional content of supermarket beverages: a cross-sectional analysis of New Zealand, Australia, Canada and the UK
  43. Assessing the potential impact of a front-of-pack nutritional rating system on food availability in school canteens: A randomised controlled trial
  44. Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health
  45. Linoleic acid and diabetes prevention – Authors' reply
  46. Use of Added Sugars Instead of Total Sugars May Improve the Capacity of the Health Star Rating System to Discriminate between Core and Discretionary Foods
  47. Effects of Different Types of Front-of-Pack Labelling Information on the Healthiness of Food Purchases—A Randomised Controlled Trial
  48. The Impact of Policies to Reduce trans Fat Consumption: A Systematic Review of the Evidence
  49. Salt substitution is a promising but unproven intervention for stroke management
  50. Effects of an Advocacy Trial on Food Industry Salt Reduction Efforts—An Interim Process Evaluation
  51. A comparison of the Health Star Rating system when used for restaurant fast foods and packaged foods
  52. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies
  53. Modelled Cost-Effectiveness of a Package Size Cap and a Kilojoule Reduction Intervention to Reduce Energy Intake from Sugar-Sweetened Beverages in Australia
  54. Labelling quality and sodium content of packaged food in India
  55. ‘The university should promote health, but not enforce it’: opinions and attitudes about the regulation of sugar-sweetened beverages in a university setting
  56. Evidence of the Potential Effectiveness of Centre-Based Childcare Policies and Practices on Child Diet and Physical Activity: Consolidating Evidence from Systematic Reviews of Intervention Trials and Observational Studies
  57. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association
  58. Changes in Typical Portion Sizes of Commonly Consumed Discretionary Foods among Australian Adults from 1995 to 2011–2012
  59. Discovery and fine-mapping of loci associated with MUFAs through trans-ethnic meta-analysis in Chinese and European populations
  60. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease
  61. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
  62. Contribution of Trans-Fatty Acid Intake to Coronary Heart Disease Burden in Australia: A Modelling Study
  63. Completeness of nutrient declarations and the average nutritional composition of pre-packaged foods in Beijing, China
  64. Estimating mean change in population salt intake using spot urine samples
  65. A Review of Population-Level Actions Targeting Reductions in Food Portion Sizes to Address Obesity and Related Non-communicable Diseases
  66. Reliable Quantification of the Potential for Equations Based on Spot Urine Samples to Estimate Population Salt Intake: Protocol for a Systematic Review and Meta-Analysis
  67. ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease
  68. Effects of Saturated Fat, Polyunsaturated Fat, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis: A Systematic Review and Meta-analysis of Randomised Controlled Feeding Trials
  69. Is Butter Back? A Systematic Review and Meta-Analysis of Butter Consumption and Risk of Cardiovascular Disease, Diabetes, and Total Mortality
  70. Effects of a community-based salt reduction program in a regional Australian population
  71. Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
  72. High variation in manufacturer-declared serving size of packaged discretionary foods in Australia
  73. Prevalence of dysglycaemia in rural Andhra Pradesh: 2005, 2010, and 2014
  74. Mean population salt intake estimated from 24-h urine samples and spot urine samples: a systematic review and meta-analysis
  75. Typical food portion sizes consumed by Australian adults: results from the 2011–12 Australian National Nutrition and Physical Activity Survey
  76. Effect of fish oil on monoepoxides derived from fatty acids during cardiac surgery
  77. Wellbeing at work among kitchen workers during organic food conversion in Danish public kitchens: a longitudinal survey
  78. Protocol for a cluster-randomised trial to determine the effects of advocacy actions on the salt content of processed foods
  79. A Comparison of the Sodium Content of Supermarket Private-Label and Branded Foods in Australia
  80. Response to Letters Regarding Article, “Circulating Omega-6 Polyunsaturated Fatty Acids and Total and Cause-Specific Mortality: The Cardiovascular Health Study”
  81. Are gluten-free foods healthier than non-gluten-free foods? An evaluation of supermarket products in Australia
  82. Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial
  83. Dietary fatty acids modulate associations between genetic variants and circulating fatty acids in plasma and erythrocyte membranes: Meta-analysis of nine studies in the CHARGE consortium
  84. Circulating cardiac biomarkers and postoperative atrial fibrillation in the OPERA trial
  85. Genetic loci associated with circulating phospholipid trans fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium
  86. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study
  87. Genetic loci associated with circulating levels of very long-chain saturated fatty acids
  88. An Evaluation of the Effects of the Australian Food and Health Dialogue Targets on the Sodium Content of Bread, Breakfast Cereals and Processed Meats
  89. Effects of vitamin E, vitamin C and polyphenols on the rate of blood pressure variation: results of two randomised controlled trials
  90. Circulating Omega-6 Polyunsaturated Fatty Acids and Total and Cause-Specific Mortality: The Cardiovascular Health Study
  91. Genome-Wide Association Study of Plasma N6 Polyunsaturated Fatty Acids Within the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium
  92. ω-3 Fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: new pieces in a complex puzzle: Table 1
  93. Circulating and Dietary Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Incidence of CVD in the Multi-Ethnic Study of Atherosclerosis
  94. Plasma Phospholipid Omega-3 Fatty Acids and Incidence of Postoperative Atrial Fibrillation in the OPERA Trial
  95. Effect of Fish Oil on Circulating Adiponectin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  96. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies
  97. Fish Oil and Post-Operative Atrial Fibrillation
  98. Genome-Wide Association Study Identifies Novel Loci Associated With Concentrations of Four Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway: Results From the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consor...
  99. Fish consumption, omega-3 fatty acids and risk of heart failure: A meta-analysis
  100. Fish Oil and Postoperative Atrial Fibrillation
  101. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis
  102. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis
  103. Association of Plasma Phospholipid Long-Chain Omega-3 Fatty Acids With Incident Atrial Fibrillation in Older Adults: The Cardiovascular Health Study
  104. (n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?1–3
  105. Omega-3 Fatty Acids and Cardiovascular Disease
  106. Genetic Loci Associated with Plasma Phospholipid n-3 Fatty Acids: A Meta-Analysis of Genome-Wide Association Studies from the CHARGE Consortium
  107. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study
  108. Sesame supplementation does not improve cardiovascular disease risk markers in overweight men and women
  109. Vitamin E Supplementation and Hepatic Drug Metabolism in Humans
  110. Inhibition of 20-Hydroxyeicosatetraenoic Acid Synthesis Using Specific Plant Lignans: In Vitro and Human Studies
  111. The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension
  112. Vitamin E metabolism
  113. Effects of  -Tocopherol and Mixed Tocopherol Supplementation on Markers of Oxidative Stress and Inflammation in Type 2 Diabetes
  114. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
  115. Assessment of Tocopherol Metabolism and Oxidative Stress in Familial Hypobetalipoproteinemia
  116. Nitration of γ-tocopherol prevents its oxidative metabolism by HepG2 cells